Eton Pharmaceuticals Inc (ETON)
3.75
0.00 (0.00%)
USD |
NASDAQ |
May 07, 12:58
Eton Pharmaceuticals Profit Margin (Quarterly): -30.85% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -30.85% |
| September 30, 2023 | -8.24% |
| June 30, 2023 | 38.00% |
| March 31, 2023 | -50.15% |
| December 31, 2022 | 10.73% |
| September 30, 2022 | -94.59% |
| June 30, 2022 | -21.17% |
| March 31, 2022 | -244.9% |
| December 31, 2021 | 17.05% |
| September 30, 2021 | -786.3% |
| Date | Value |
|---|---|
| June 30, 2021 | -65.73% |
| March 31, 2021 | 43.00% |
| December 31, 2020 | -9.49K% |
| September 30, 2020 | |
| June 30, 2020 | -23.65K% |
| March 31, 2020 | -9.14K% |
| December 31, 2019 | -587.4% |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | -1.48K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-23.65K%
Minimum
Jun 2020
43.00%
Maximum
Mar 2021
-2.75K%
Average
-57.94%
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 25.58% |
| Evoke Pharma Inc | -118.6% |
| Outlook Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -6.37% |
| Return on Assets | -3.27% |
| Return on Invested Capital | -4.52% |
| Gross Profit Margin (Quarterly) | 49.64% |
| Operating Margin (Quarterly) | -27.25% |
| Return on Net Operating Assets | -11.11% |